Track Insider Trading in Facebook, Zynga, Arena Pharmaceuticals, Lululemon Athletica, Weatherford International, and Bank of America



Insiderslab.com is has released insider trading report for US market investors to track the performance of company insiders, which can help the portfolios. Today’s report will cover the following stocks: Facebook (NASDAQ:FB), Zynga (NASDAQ:ZNGA), Arena Pharmaceuticals (NASDAQ:ARNA), Lululemon Athletica (NASDAQ:LULU), Weatherford International (NYSE:WFT), and Bank of America (NYSE:BAC).
 
(Read full report by clicking the link below, you may need to copy and paste the full link to your browser.)
 
Report Highlights:
 
Facebook Inc (NASDAQ:FB)): By the end of last trading session, the shares of Facebook (NASDAQ:FB) lost US$0.29 (or 0.64%) to US$44.75 with 68.05 million shares exchanged hands, compared to daily average volume of 65.38 million. Insiderslab.com found company VP Marketing & Bus. Part., David B. Fischer, sold his shares at the price of US$43.38 on September 11. One day before, the company Chief Operating Officer, Sheryl Sandberg, sold her shares at the price of US$43.69, which was part of her US$123.10 million selling within last three months. Investors may want to find out how Facebook insiders like CEOs, CFOs and Directors are thinking about the future of the company. Check this insider trade report for FB here.
 
Read Full Report: http://www.insiderslab.com/PR3/091313A/FB/Facebook.pdf
 
Zynga Inc (NASDAQ:ZNGA): By the end of last trading session, Zynga (NASDAQ:ZNGA) shares earned 0.67% to US$3.02 with about 14.74 million shares exchanged hands for the session, compared to its average volume of 15.65 million shares. Insiderslab.com found company Directors, Stanley J. Meresman and Jeffrey Katzenberg, sold their shares at the price of US$2.86 on September 3. Investors may want to find out how Zynga insiders like CEOs, CFOs and Directors are thinking about the future of the company.
 
Read Full Report: http://www.insiderslab.com/PR3/091313A/ZNGA/Zynga.pdf
 
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA): By the end of last trading session, Arena Pharmaceuticals (NASDAQ:ARNA) dropped 2.57% to US$5.87 with about 9.45 million shares exchanged hands for the session, compared to its average volume of 4.61 million shares. Insiderslab.com found company EVP & Chief Scientific Officer, Dominic P. Behan, sold his shares at the price of US$6.31 for about US$1.26 million on September 10. Insiderslab.com believes that it is a clever way to check if insiders like CEOs, CFOs, and Directors in Arena are starting to sell more company shares. See insider trade report for ARNA here.
 
Read Full Report: http://www.insiderslab.com/PR3/091313A/ARNA/Arena.pdf
 
Today Insiderslab.com also observed abnormal trade volume for the following companies; insiders may involve trading in these companies. It will take some time for insiders to report their trades. Read these reports and add these companies into your Insider Trade Radar.
 
Lululemon Athletica inc. (NASDAQ:LULU):
 
Read Full Report: http://www.insiderslab.com/PR3/091313A/LULU/LululemonAthletica.pdf
 
Weatherford International Ltd (NYSE:WFT):
 
Read Full Report: http://www.insiderslab.com/PR3/091313A/WFT/Weatherford.pdf
 
Bank of America Corp (NYSE:BAC):
 
Read Full Report: http://www.insiderslab.com/PR3/091313A/BAC/BankofAmerica.pdf
 
Insider Filing Source Reference: All observations, analysis and reports are based on public information released by the U.S. Securities and Exchange Commission.
 
About Insiderslab.com:
 
Insiderslab.com covers insider trade data in major stock markets in the U.S., Hong Kong, Mainland China, and Singapore.  Insiderslab.com features a team of experienced data analysts striving to provide the investment community with the tools, software, and data necessary to carry out more effective investment research.
 
Important Disclaimer:
Please visit insiderslab.com/disclaimers/disclaimers.php for details.
Source:
www.insiderslab.com
www.insiderslab.com

Reported on Sep 13, 2013

 
More Insider News ...

Today's Notable Trades


XO GROUP INC. (XOXO)
Senior Officer (EVP, Local Enterprise): Savilia Kristin

Sold 11,426 Common Stock (Non-Derivative security at $11.940) on Aug 18, 2014. Direct holding 77,309 shares/units after transaction. Holdings decreased -12.88%.
Filing date: Aug 19, 2014. Record updated at 22:53:14.
 
MOVE INC (MOVE)
Senior Officer (SVP & Chief Accounting Officer): Wehr Patricia A.

Acquired 18,750 Common Stock (Non-Derivative security at $9.040) on Aug 18, 2014. Direct holding 49,003 shares/units after transaction. Holdings increased 61.98%.
Filing date: Aug 19, 2014. Record updated at 22:52:39.
 
CONTROL4 CORP (CTRL)
Senior Officer (SVP of Sales): Arnold James B.

Sold 13,000 Common Stock (Non-Derivative security at $15.222) on Aug 18, 2014. Direct holding 0 shares/units after transaction. Holdings decreased -100.00%.
Filing date: Aug 19, 2014. Record updated at 22:52:21.
 
InvenSense Inc (INVN)
Senior Officer (Chief Financial Officer): KROCK ALAN

Sold 1,666 Common Stock (Non-Derivative security at $24.695) on Aug 18, 2014. Direct holding 5,424 shares/units after transaction. Holdings decreased -23.50%.
Filing date: Aug 19, 2014. Record updated at 22:52:04.
 
ZILLOW INC (Z)
Senior Officer (CFO & Treasurer): Cohen Chad M

Acquired 1,775 Class A Common Stock (Non-Derivative security at $36.360) on Aug 18, 2014. Direct holding 2,175 shares/units after transaction. Holdings increased 443.75%.
Filing date: Aug 19, 2014. Record updated at 22:51:28.
 
MACROGENICS INC (MGNX)
Senior Officer (Senior VP, Clinical Dev.): Wigginton Jon Marc

Sold 5,000 Common Stock (Non-Derivative security at $20.520) on Aug 18, 2014. Direct holding 0 shares/units after transaction. Holdings decreased -100.00%.
Filing date: Aug 19, 2014. Record updated at 22:50:18.
 
TAYLOR CAPITAL GROUP INC (TAYC)
Director: Moskow Michael H

Sold 150,000 Common Stock (Option to Buy) (Derivative security at conversion or exercise price: $20.000) on Aug 18, 2014. Direct holding 0 shares/units after transaction. Common Stock (Option to Buy) expires on Dec 23, 16. Holdings decreased -100.00%.
Filing date: Aug 19, 2014. Record updated at 22:50:00.
 
ROYAL BANCSHARES OF PENNSYLVANIA INC (RBPAA)
Director: HARTMAN WILLIAM R

Acquired 17,446 ROYAL BANCSHARES OF PENNSYLVANIA CLASS A COMMON (Non-Derivative security at $1.540) on Aug 15, 2014. Direct holding 186,980 shares/units after transaction. Holdings increased 10.29%.
Filing date: Aug 19, 2014. Record updated at 22:49:25.
 
MICROCHIP TECHNOLOGY INC (MCHP)
Senior Officer (VP and CFO): Bjornholt James Eric

Acquired 3,342 Common Stock (Non-Derivative security at $47.370) on Aug 15, 2014. Indirect holding 15,600 shares/units after transaction. Holdings increased 27.26%.
Filing date: Aug 19, 2014. Record updated at 22:47:57.
 
CASCADE MICROTECH INC (CSCD)
Senior Officer (VP, Human Resources): Raim Ellen

Sold 2,726 Common Stock (Non-Derivative security at $11.080) on Aug 15, 2014. Direct holding 20,913 shares/units after transaction. Holdings decreased -11.53%.
Filing date: Aug 19, 2014. Record updated at 22:44:45.
 
Read more

Disclaimer

InsidersLab.com focuses on tracking and monitoring insider trading activities in the US stocks market. "Insider Trading" means trading activities created by company directors, senior officers, individual substantial shareholders, and institutional shareholders. InsidersLab.com does not represent, warrant, nor endorse the accuracy, reliability, completeness or timeliness of any of the information, content, views, opinions, recommendations or advertisements (collectively, the "Materials") contained on, distributed through, or linked, downloaded or accessed from any of the services contained on the website (the "Service"), nor the quality of any products, information or other materials displayed, purchased, or obtained by you as a result of an advertisement or any other information or offer in or in connection with the Service (the "Products"). InsidersLab.com collects insider trading information from different public sources such as newspapers, financial information websites, and government statistics publications. You hereby acknowledge that any reliance upon any Materials shall be at your sole risk. In particular, none of the Materials is provided on the InsidersLab.com website or emails with a view to inviting, inducing or encouraging any person to make any kind of investment decision. Securities or other investments referred to in the Materials may not be suitable for you and you should not make any kind of investment decision in relation to them without first obtaining independent investment advice from a person authorized to give it.